Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2011
Report date:
2011

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1100 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
N'-(ethylcarbonimidoyl)-N,N-dimethylpropane-1,3-diamine monohydrochloride
EC Number:
247-361-2
EC Name:
N'-(ethylcarbonimidoyl)-N,N-dimethylpropane-1,3-diamine monohydrochloride
Cas Number:
25952-53-8
Molecular formula:
C8H17N3.ClH
IUPAC Name:
N-[3-(dimethylamino)propyl]-N'-ethylcarbodiimide hydrochloride
Test material form:
solid

Test animals

Species:
rat
Strain:
Wistar
Remarks:
Crl: WI(Han)
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River, 97633 Sulzfeld, Germany
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: 8 to 11 weeks old
- Weight at study initiation: 162 to 189 g for all animals
- Fasting period before study: No
- Housing: Full barrier in an air-conditioned room. Housed individually in IVC cages including saw fibre bedding.
- Diet (e.g. ad libitum): Free access to Altromin maintenance diet.
- Water (e.g. ad libitum): Free access to tap water.
- Acclimation period: At least 5 days.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 55 +/- 10%
- Air changes (per hr): 10 per hour
- Photoperiod (hrs dark / hrs light): Artificial lighting (12 hours light/dark cycles)

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Remarks:
Aqua ad injectionem
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 0.2 g/mL or 0.03 g/mL
- Amount of vehicle (if gavage): 10 mL/Kg
- Justification for choice of vehicle: Standard vehicle for test type and chosen based on its non-toxic characteristics.

MAXIMUM DOSE VOLUME APPLIED: 10 mL/Kg

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: No toxicity data available and accordingly limit dose chosen.
Doses:
The starting dose was selected to be 2000 mg/kg bw. This was then followed by two further doses of 300 mg/kg bw.
No. of animals per sex per dose:
3 females per step (3 at 2000 mg/kg bw and 6 at 300 mg/kg bw)
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were weighed on Day 1 (prior to dosing) and days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: Clinical signs were noted on the day of dosing and then once daily during the observation period.
Statistics:
Not applicable to study type

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50 cut-off
Effect level:
500 mg/kg bw
Based on:
test mat.
Mortality:
All animals that received 2000 mg/kg bw were found dead within 3 hours post dose (3/3). During step two (300 mg/kg bw), one animal was found dead 1 day post dose (1/6).
Clinical signs:
other: 2000 mg/kg bw: Signs observed in two animals included recumbency, apathy, ataxia and half-eyelid closure. 300 mg/kg bw: The most relevant signs at this dose (observed in the majority of animals) were piloerection, reduced spontaneous activity, recumbency
Gross pathology:
2000 mg/kg bw: No significant necropsy findings were noted.
300 mg/kg bw: In the animal found dead a bloated stomach, duodenum, jejunum, ileum with Peyer’s patches, mesenteric lymph node, caecum and colon were noted along with a red discolouration of the lung. Red spots in the lung were also observed in another surviving animal and no other significant findings were observed in the groups

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
A reliable, guideline study is available providing an LD50 cut-off value of 500 mg/kg bw to rats.